Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Immunotherapy in hepatocellular carcinoma.

Buonaguro L, Mauriello A, Cavalluzzo B, Petrizzo A, Tagliamonte M.

Ann Hepatol. 2019 Mar - Apr;18(2):291-297. doi: 10.1016/j.aohep.2019.04.003. Epub 2019 Apr 25. Review.

2.

Assessing the human footprint on the sea-floor of coastal systems: the case of the Venice Lagoon, Italy.

Madricardo F, Foglini F, Campiani E, Grande V, Catenacci E, Petrizzo A, Kruss A, Toso C, Trincardi F.

Sci Rep. 2019 Apr 29;9(1):6615. doi: 10.1038/s41598-019-43027-7.

3.

Impact of presenting patient characteristics on surgical complications and morbidity in early onset scoliosis.

Segreto FA, Vasquez-Montes D, Bortz CA, Horn SR, Diebo BG, Vira S, Kelly JJ, Stekas N, Ge DH, Ihejirika YU, Lafage R, Lafage V, Karamitopoulos M, Delsole EM, Hockley A, Petrizzo AM, Buckland AJ, Errico TJ, Gerling MC, Passias PG.

J Clin Neurosci. 2019 Apr;62:105-111. doi: 10.1016/j.jocn.2018.12.007. Epub 2019 Jan 8.

PMID:
30635164
4.

Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients.

Petrizzo A, Tagliamonte M, Mauriello A, Costa V, Aprile M, Esposito R, Caporale A, Luciano A, Arra C, Tornesello ML, Buonaguro FM, Buonaguro L.

J Transl Med. 2018 Oct 19;16(1):286. doi: 10.1186/s12967-018-1662-9.

5.

Comparative Analysis of Two Transforaminal Lumbar Interbody Fusion Techniques: Open TLIF Versus Wiltse MIS TLIF.

Ge DH, Stekas ND, Varlotta CG, Fischer CR, Petrizzo A, Protopsaltis TS, Passias PG, Errico TJ, Buckland AJ.

Spine (Phila Pa 1976). 2019 May 1;44(9):E555-E560. doi: 10.1097/BRS.0000000000002903.

PMID:
30325884
6.

Potentiating cancer vaccine efficacy in liver cancer.

Tagliamonte M, Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Buonaguro L.

Oncoimmunology. 2018 Jul 23;7(10):e1488564. doi: 10.1080/2162402X.2018.1488564. eCollection 2018.

7.

Incidence, trends, and associated risks of developmental hip dysplasia in patients with Early Onset and Adolescent Idiopathic Scoliosis.

Segreto FA, Vasquez-Montes D, Brown AE, Bortz C, Horn SR, Diebo BG, Zhou PL, Vira S, Baker JF, Petrizzo AM, Lafage R, Lafage V, Errico TJ, Passias PG.

J Orthop. 2018 Aug 15;15(3):874-877. doi: 10.1016/j.jor.2018.08.015. eCollection 2018 Sep.

8.

Progressive Infantile Scoliosis Managed With Osteopathic Manipulative Treatment.

Petrizzo AM, Frangella NJ.

J Am Osteopath Assoc. 2018 Jul 1;118(7):431. doi: 10.7556/jaoa.2018.096. No abstract available.

PMID:
29946659
9.

Evaluation of the perception of clinical competencies by nursing students in the different clinical settings: an observational study.

Notarnicola I, Stievano A, Pulimeno A, Iacorossi L, Petrizzo A, Gambalunga F, Rocco G, Petrucci C, Lancia L.

Ann Ig. 2018 May-Jun;30(3):200-210. doi: 10.7416/ai.2018.2211.

10.

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma.

Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L.

Infect Agent Cancer. 2018 Mar 27;13:10. doi: 10.1186/s13027-018-0183-8. eCollection 2018. Review.

11.

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting.

Petrizzo A, Mauriello A, Luciano A, Rea D, Barbieri A, Arra C, Maiolino P, Tornesello M, Gigantino V, Botti G, Ciliberto G, Buonaguro FM, Tagliamonte M, Buonaguro L.

Oncotarget. 2017 Dec 8;9(3):3576-3589. doi: 10.18632/oncotarget.23181. eCollection 2018 Jan 9.

12.

High resolution multibeam and hydrodynamic datasets of tidal channels and inlets of the Venice Lagoon.

Madricardo F, Foglini F, Kruss A, Ferrarin C, Pizzeghello NM, Murri C, Rossi M, Bajo M, Bellafiore D, Campiani E, Fogarin S, Grande V, Janowski L, Keppel E, Leidi E, Lorenzetti G, Maicu F, Maselli V, Mercorella A, Montereale Gavazzi G, Minuzzo T, Pellegrini C, Petrizzo A, Prampolini M, Remia A, Rizzetto F, Rovere M, Sarretta A, Sigovini M, Sinapi L, Umgiesser G, Trincardi F.

Sci Data. 2017 Sep 5;4:170121. doi: 10.1038/sdata.2017.121.

13.

Drosophila dyskerin is required for somatic stem cell homeostasis.

Vicidomini R, Petrizzo A, di Giovanni A, Cassese L, Lombardi AA, Pragliola C, Furia M.

Sci Rep. 2017 Mar 23;7(1):347. doi: 10.1038/s41598-017-00446-8.

14.

Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.

Petrizzo A, Buonaguro L.

J Immunother Cancer. 2016 Nov 15;4:71. eCollection 2016.

15.

Immunological effects of a novel RNA-based adjuvant in liver cancer patients.

Circelli L, Petrizzo A, Tagliamonte M, Heidenreich R, Tornesello ML, Buonaguro FM, Buonaguro L.

Cancer Immunol Immunother. 2017 Jan;66(1):103-112. doi: 10.1007/s00262-016-1923-5. Epub 2016 Nov 10.

PMID:
27832318
16.

Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery.

Petrizzo A, Caruso FP, Tagliamonte M, Tornesello ML, Ceccarelli M, Costa V, Aprile M, Esposito R, Ciliberto G, Buonaguro FM, Buonaguro L.

Sci Rep. 2016 Jul 8;6:29258. doi: 10.1038/srep29258.

17.

A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice.

Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Rea D, Barbieri A, Arra C, Maiolino P, Tornesello M, Ciliberto G, Buonaguro FM, Buonaguro L.

J Transl Med. 2016 Feb 24;14:58. doi: 10.1186/s12967-016-0812-1.

18.

Combinatorial immunotherapy strategies for hepatocellular carcinoma.

Tagliamonte M, Petrizzo A, Tornesello ML, Ciliberto G, Buonaguro FM, Buonaguro L.

Curr Opin Immunol. 2016 Apr;39:103-13. doi: 10.1016/j.coi.2016.01.005. Epub 2016 Feb 4. Review.

PMID:
26851637
19.

Functional characterization of biodegradable nanoparticles as antigen delivery system.

Petrizzo A, Conte C, Tagliamonte M, Napolitano M, Bifulco K, Carriero V, De Stradis A, Tornesello ML, Buonaguro FM, Quaglia F, Buonaguro L.

J Exp Clin Cancer Res. 2015 Oct 6;34:114. doi: 10.1186/s13046-015-0231-9.

20.

Estuarine circulation in the Taranto Seas.

Pascalis FD, Petrizzo A, Ghezzo M, Lorenzetti G, Manfè G, Alabiso G, Zaggia L.

Environ Sci Pollut Res Int. 2016 Jul;23(13):12515-34. doi: 10.1007/s11356-015-5389-3. Epub 2015 Sep 26.

PMID:
26408109
21.

Systems Biology Approach for Cancer Vaccine Development and Evaluation.

Circelli L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L.

Vaccines (Basel). 2015 Jul 14;3(3):544-55. doi: 10.3390/vaccines3030544. Review.

22.

Cellular prognostic markers in hepatocellular carcinoma.

Buonaguro L, Tagliamonte M, Petrizzo A, Damiano E, Tornesello ML, Buonaguro FM.

Future Oncol. 2015;11(11):1591-8. doi: 10.2217/fon.15.39. Review.

PMID:
26043213
23.

Does aspirin administration increase perioperative morbidity in patients with cardiac stents undergoing spinal surgery?

Cuellar JM, Petrizzo A, Vaswani R, Goldstein JA, Bendo JA.

Spine (Phila Pa 1976). 2015 May 1;40(9):629-35. doi: 10.1097/BRS.0000000000000695.

PMID:
26030214
24.

Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model.

Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Arra C, Maiolino P, Izzo F, Tornesello ML, Aurisicchio L, Ciliberto G, Buonaguro FM, Buonaguro L.

Cancer Immunol Immunother. 2015 Oct;64(10):1305-14. doi: 10.1007/s00262-015-1698-0. Epub 2015 May 6.

PMID:
25944003
25.

Loss of Drosophila pseudouridine synthase triggers apoptosis-induced proliferation and promotes cell-nonautonomous EMT.

Vicidomini R, Di Giovanni A, Petrizzo A, Iannucci LF, Benvenuto G, Nagel AC, Preiss A, Furia M.

Cell Death Dis. 2015 Mar 26;6:e1705. doi: 10.1038/cddis.2015.68.

26.

Outcomes and complications of the midline anterior approach 3 years after lumbar spine surgery.

Fischer CR, Braaksma B, Peters A, Weinreb JH, Nalbandian M, Spivak JM, Petrizzo A.

Adv Orthop. 2014;2014:142604. doi: 10.1155/2014/142604. Epub 2014 Dec 22.

27.

Feasibility of a cost-effective, video analysis software-based mobility protocol for objective spine kinematics and gait metrics: a proof of concept study.

Paul JC, Petrizzo A, Rizzo JR, Bianco K, Maier S, Errico TJ, Lafage V.

PM R. 2015 Mar;7(3):336-9. doi: 10.1016/j.pmrj.2014.11.007. Epub 2014 Dec 24.

28.

Antigen-specific vaccines for cancer treatment.

Tagliamonte M, Petrizzo A, Tornesello ML, Buonaguro FM, Buonaguro L.

Hum Vaccin Immunother. 2014;10(11):3332-46. doi: 10.4161/21645515.2014.973317. Review.

29.

Postoperative spinal fusion care in pediatric patients: Co-management decreases length of stay.

Rosenberg RE, Ardalan K, Wong W, Patel S, Gold-von Simson G, Feldman D, Lonner B, Petrizzo A, Poitevien P, Gertz SJ, Dreyer B.

Bull Hosp Jt Dis (2013). 2014;72(3):197-203.

30.

Systems vaccinology for cancer vaccine development.

Petrizzo A, Tagliamonte M, Tornesello M, Buonaguro FM, Buonaguro L.

Expert Rev Vaccines. 2014 Jun;13(6):711-9. doi: 10.1586/14760584.2014.913484. Epub 2014 Apr 28. Review.

PMID:
24766452
31.

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach.

Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L.

J Transl Med. 2014 Jan 15;12:11. doi: 10.1186/1479-5876-12-11.

32.

Challenges in cancer vaccine development for hepatocellular carcinoma.

Buonaguro L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM.

J Hepatol. 2013 Oct;59(4):897-903. doi: 10.1016/j.jhep.2013.05.031. Epub 2013 May 25. Review. Erratum in: J Hepatol. 2014 Jan;60(1):237.

33.

Pattern of activation of human antigen presenting cells by genotype GII.4 norovirus virus-like particles.

Ponterio E, Petrizzo A, Di Bartolo I, Buonaguro FM, Buonaguro L, Ruggeri FM.

J Transl Med. 2013 May 24;11:127. doi: 10.1186/1479-5876-11-127.

34.

Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders.

Petrizzo A, Tornesello ML, Napolitano M, D'Alessio G, Salomone Megna A, Dolcetti R, De Re V, Wang E, Marincola FM, Buonaguro FM, Buonaguro L.

PLoS One. 2012;7(9):e44870. doi: 10.1371/journal.pone.0044870. Epub 2012 Sep 18.

35.

Immunogenomics approaches for vaccine evaluation.

Petrizzo A, Tornesello M, Buonaguro FM, Buonaguro L.

J Immunotoxicol. 2012 Jul-Sep;9(3):236-40. doi: 10.3109/1547691X.2012.707698. Review.

PMID:
22894136
36.

Innate immunity and hepatitis C virus infection: a microarray's view.

Buonaguro L, Petrizzo A, Tornesello ML, Buonaguro FM.

Infect Agent Cancer. 2012 Mar 26;7(1):7. doi: 10.1186/1750-9378-7-7.

37.

Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?

Cools N, Petrizzo A, Smits E, Buonaguro FM, Tornesello ML, Berneman Z, Buonaguro L.

Immunotherapy. 2011 Oct;3(10):1203-22. doi: 10.2217/imt.11.110. Review.

PMID:
21995572
38.

Translating tumor antigens into cancer vaccines.

Buonaguro L, Petrizzo A, Tornesello ML, Buonaguro FM.

Clin Vaccine Immunol. 2011 Jan;18(1):23-34. doi: 10.1128/CVI.00286-10. Epub 2010 Nov 3. Review.

39.

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders.

Buonaguro L, Petrizzo A, Tornesello M, Napolitano M, Martorelli D, Castello G, Beneduce G, De Renzo A, Perrella O, Romagnoli L, Sousa V, De Re V, Dolcetti R, Buonaguro FM.

J Transl Med. 2010 Feb 19;8:18. doi: 10.1186/1479-5876-8-18.

40.

Revision of a lumbar disc arthroplasty following late infection.

Spivak JM, Petrizzo AM.

Eur Spine J. 2010 May;19(5):677-81. doi: 10.1007/s00586-009-1226-z. Epub 2009 Nov 25.

41.

Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy.

Buonaguro L, Petrizzo A, Tagliamonte M, Vitone F, Re MC, Pilotti E, Casoli C, Sbreglia C, Perrella O, Tornesello ML, Buonaguro FM.

Infect Agent Cancer. 2008 Oct 10;3:13. doi: 10.1186/1750-9378-3-13.

42.

Allograft versus no graft with a posterior multisegmented hook system for the treatment of idiopathic scoliosis.

Betz RR, Petrizzo AM, Kerner PJ, Falatyn SP, Clements DH, Huss GK.

Spine (Phila Pa 1976). 2006 Jan 15;31(2):121-7.

PMID:
16418628
43.

[Assessment of left internal thoracic artery anastomosis with left anterior descending coronary artery by Doppler echocardiography].

Arruda A, Campos Filho O, Ribeiro E, Petrizzo A, Andrade JL, Carvalho AC, Buffolo E, Martinez E, Mathias Júnior W.

Arq Bras Cardiol. 1997 Dec;69(6):413-9. Portuguese.

PMID:
9609014
44.

[Myocardial revascularization through small left anterior minithoracotomy].

Teles CA, Aguiar LF, Petrizzo A, Ribeiro E, Silva LA, Buffolo E.

Arq Bras Cardiol. 1997 Feb;68(2):113-6. Portuguese.

PMID:
9433837
45.

Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction.

Ribeiro EE, Silva LA, Carneiro R, D'Oliveira LG, Gasquez A, Amino JG, Tavares JR, Petrizzo A, Torossian S, Duprat Filho R, et al.

J Am Coll Cardiol. 1993 Aug;22(2):376-80.

46.

[Thrombolysis with intravenous APSAC in patients with acute myocardial infarction].

Ribeiro E, Silva LA, Petrizzo A, Torossian SP, Oliveira JL, Buffollo E, Duprat Filho R.

Arq Bras Cardiol. 1991 Jul;57(1):5-8. Portuguese.

PMID:
1823762
47.

[Treatment of pulmonary thromboembolism with extrinsic plasminogen activator. A case report].

Silva LA, Ribeiro E, Torossian SP, Oliveira JL, Salvadori RA, Petrizzo A, Papa ED, Aboud E, Duprat Filho R.

Arq Bras Cardiol. 1989 Sep;53(3):167-9. Portuguese.

PMID:
2517012

Supplemental Content

Loading ...
Support Center